Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406341
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2006-11-29
Brief Title:
Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
Sponsor:
Sirion Therapeutics Inc
Organization:
Sirion Therapeutics Inc
Study Overview
Official Title:
Phase 3 Confimatory Study of 005 Difluprednate Ophthalmic Emulsion in the Treament of Postoperative Inflammation
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation
Detailed Description:
The objective of this phase 3 study is to assess the efficacy and safety of 005 difluprednate ophthalmic emulsion in patients with intraocular postoperative inflammation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None